Feb 13,2018

The Road Behind, the Road Ahead, and What We Heard at the 2018 J.P. Morgan Healthcare Conference

Reimbursements are key, and digital therapeutics for chronic conditions are poised for success — New entrants with reimbursable offerings differentiate themselves from health and wellness offerings that offer no form of repayment for patients or providers. In other words, despite the consumerization of healthcare that has occurred over the past years, the traditional mindset that health services are paid for by payers or employers still drives patient/consumer decision making.

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 14,2018

Voluntis signs contract with US payer WellDyneRX for coverage of a digital therapeutic

Voluntis, a company specialized in digital therapeutics, and WellDyneRx, a full-service, independent pharmacy benefit manager (PBM), announced today that Voluntis’ Insulia will be incorporated into the recently-launched WellManaged-Diabetes program. Insulia will be covered as part of WellDyneRx’s program based on members successfully titrating their insulin doses and achieving blood glucose goals in a value-based reimbursement model, which is the primary model being leveraged by Voluntis in the market today.

COLLABORATION PARTNERSHIP

#insurance

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jun 21,2017

DarioHealth Looks to Accelerate Market Penetration with Expanded Health Insurance Coverage to Target up to 10 Million Consumers

DarioHealth, a leading global digital health company with mobile health and big data solutions, today announced that it is expanding its insurance coverage provider network across the U.S. with additional service providers that will be able to target up to 10 million consumers with diabetes. Earlier this year, DarioHealth began offering a 3rd party insurance coverage option for U.S. consumers who wanted to have their DarioHealth products reimbursed by insurance. After a successful pilot program, industry leader DarioHealth is expanding its provider network as it continues market acceleration with additional insurance coverage access for U.S. consumers.

PRODUCT

#mobile app

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jun 13,2016

BIO panel: Fast, robust data will clear reimbursement path for digital therapeutics

Digital health and digital therapeutics will produce a tremendous amount of data, which could be the key to getting them reimbursed by payers, according to panelists at BIO 2016 last week. UCSF Professor of Health Economics and Health Services Research Kathryn Phillips led a panel that included Rowan Chapman, managing director of new business ventures at GE Ventures; Evidation Health CEO Deborah Kilpatrick; and Nicole Littman, vice president client services at Quorum Consulting. The panelists talked about Proteus Digital Health's sensor-embedded pharmaceuticals as one example of a digital medicine or digital therapeutic. Littman said few payers have elected to cover Proteus so far.

#reimbursement

#connected device

View Analyst & Ambassador Comments
Go to original news
Jul 14,2015

LabStyle Innovations' Dario Diabetes Management Solution Now Reimbursed Through a Majority of Medical Plans in Canada

LabStyle Innovations Corp., today announced the Dario Diabetes Management Solution's Smart Meter test strips are now reimbursed in Canada by most private insurance plans after the Dario was launched in Canada through major pharmacies including London Drugs and online at www.mydario.ca. "Reimbursement of the recurring expense of test strips will make it even easier for Canadians to adopt Dario", stated Erez Raphael, President and CEO of LabStyle Innovations.

PRODUCT

#mobile app

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Apr 28,2014

LabStyle Innovations Announces Reimbursement Coverage for the use of the Dario™ Personalized Smart Meter in Italy

LabStyle Innovations, developer of the Dario™ Diabetes Management Solution, today announced that it has received national approval and regional reimbursement for the Dario™ Personalized Smart Meter in Italy.

PRODUCT

#reimbursement

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
Jun 25,2014

LabStyle Innovations Awarded NHS Reimbursement Status in the United Kingdom for the Dario™ Smart Meter Strips and Lancets

LabStyle Innovations Corp. (OTCQB: DRIO)announced today that it has been granted reimbursement status for strips and lancets to be utilized together with the patented Dario™ Smart Meter, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland. Dario™ is a cloud-based, diabetes management solution which includes novel software applications combined with the stylish, 'all-in-one', pocket-sized, Dario Smart Meter which interfaces with a user's mobile device to form the overall Dario™ Diabetes Management Solution, allowing diabetics to monitor their blood sugars and other activities using their mobile devices.

PRODUCT

#reimbursement

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 03,2014

LabStyle Innovations Awarded Reimbursement Status in Australia for the Dario Smart Meter Strips

LabStyle Innovations, the maker of the Dario™ smart meter for diabetics, announced today that it has been granted reimbursement status for its Dario™ blood glucose test strips to be utilized together with the patented Dario™ smart meter in Australia. This achievement marks another milestone in the continuing worldwide roll out of Dario™.

PRODUCT

#connected device

#mobile app

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jan 07,2022

Why providers are key to digital therapeutic uptake

Digital therapeutics are a growing field in the larger digital health space, but they’re still relatively new. What’s the state of the market, and how can the companies behind these products encourage their uptake? During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

#pdt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jan 17,2022

5 Takeaways: The Rise Of Digital Therapeutics (DTx) In 2022

At the BIOMEDevice Conference last month, Scott Thielman moderated a panel titled Is There an App for That? The Rise of Prescription Digital Therapeutics. In the article, there are five takeaways from the experts’ discussion.

#cbt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Subscribe to REIMBURSEMENT